Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Acorda slides on complete response for diazepam nasal spray

May 3, 2014 1:30 AM UTC

Acorda Therapeutics Inc. (NASDAQ:ACOR) was down $3.51 (10%) to $32.39 on Friday after FDA issued a complete response letter for Plumiaz diazepam nasal spray to treat acute repetitive seizures in epile...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article